Medicare Enrolled

Dr. Frank Greskovich, M.D.

Optician · Pensacola, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
4724 N DAVIS HWY, Pensacola, FL 32503
8506964000
In practice since 2005 (20 years)
NPI: 1285611236 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Greskovich from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Greskovich? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Greskovich

Dr. Frank Greskovich is an optician specialist in Pensacola, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Greskovich performed 51,919 Medicare services across 4,975 unique beneficiaries.

Between the years covered by Open Payments, Dr. Greskovich received a total of $7,493 from 54 pharmaceutical and/or device companies across 381 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Greskovich is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 2% volume in FL $7,493 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 59571 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
51,919
Medicare services
Top 2% in FL for optician
4,975
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,596 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Testosterone injection
An injection of testosterone cypionate, a form of testosterone hormone. The dose is measured in milligrams.
32,610 $0 $1
Contrast dye for imaging (iodine-based)
A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures.
6,550 $0 $3
Denosumab injection (Prolia/Xgeva) 2,760 $19 $46
Genetic analysis to identify organisms
A laboratory test that uses genetic analysis and an amplified probe technique to identify specific organisms.
2,052 $34 $156
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,279 $88 $224
Automated urinalysis
An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine.
1,100 $2 $16
Gadobenate dimeglumine injection
Administration of gadobenate dimeglumine, a contrast agent used to enhance imaging results.
630 $1 $16
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
525 $58 $148
Nucleic acid test for multiple organisms
A laboratory test that uses amplified probe techniques to detect the genetic material of multiple organisms in a sample.
513 $69 $364
Injection, triptorelin pamoate, 3.75 mg 465 $288 $2,196
Yeast/candida DNA test
A laboratory test that uses an amplified probe technique to detect the presence of Candida species, a type of yeast, in a patient sample.
342 $34 $123
Infectious disease DNA/RNA test
A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism.
342 $34 $161
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
236 $7 $94
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
214 $179 $664
VRE nucleic acid detection test
A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample.
171 $34 $177
Staphylococcus aureus DNA test
A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample.
171 $34 $149
MRSA nucleic acid detection test
A laboratory test that uses amplified probe techniques to detect the genetic material of methicillin-resistant Staphylococcus aureus (MRSA) bacteria.
171 $34 $149
Strep A nucleic acid amplification test
A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present.
171 $34 $123
Group B Strep DNA test
A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria.
171 $34 $123
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
166 $10 $93
Piflufolastat F-18 diagnostic injection
A diagnostic injection of the radioactive tracer piflufolastat F-18 used for imaging. The dose specified is 1 millicurie.
135 $474 $1,380
Subcutaneous or intramuscular chemotherapy injection
This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle.
125 $25 $141
Abdominal X-ray, 1 view
An X-ray image of the abdomen taken from a single angle to visualize internal structures.
121 $22 $84
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
84 $117 $343
Blood creatinine level test
A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function.
68 $5 $30
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
66 $105 $297
MRI of pelvis with and without contrast
A magnetic resonance imaging scan of the pelvic area performed both before and after the administration of a contrast dye to enhance image detail.
57 $274 $3,458
Ceftriaxone antibiotic injection
This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered.
56 $0 $36
Complete ultrasound of retroperitoneum
An ultrasound examination of the structures located behind the abdominal cavity.
53 $64 $361
Prostate gland biopsy
A procedure to remove small samples of tissue from the prostate gland for laboratory examination.
46 $106 $730
Transrectal ultrasound of the pelvis
An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures.
46 $26 $418
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
45 $40 $115
CT scan of abdomen and pelvis with contrast
A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures.
42 $271 $1,776
Simple change of bladder tube 37 $64 $367
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
34 $135 $301
Simple insertion of temporary bladder tube
A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder.
33 $47 $249
CT scan of abdomen and pelvis, without contrast
A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye.
25 $143 $892
Transurethral prostate removal with electrocautery
This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding.
23 $592 $2,644
Complex urodynamic pressure flow study
A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning.
22 $286 $898
CT scan of abdomen with and without contrast
A CT scan of the abdomen performed both before and after the administration of contrast dye to provide detailed images of internal structures.
21 $183 $1,192
Ureteral stent insertion via endoscope
A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder.
20 $99 $1,986
Shock wave crushing of kidney stones
A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body.
19 $463 $3,538
Nuclear medicine scan from skull base to mid-thigh with CT
A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan.
19 $1,199 $4,120
Bladder instillation of anti-cancer drug
A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue.
16 $66 $420
Ureteral stone crushing with stent insertion
An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open.
15 $315 $1,272
Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm
This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters.
14 $216 $1,621
Chest X-ray, 2 views
An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall.
14 $25 $96
Non-needle muscle activity measurement of bladder and bowel openings
This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles.
12 $26 $606
Abdominal device insertion with pressure and urine flow study
A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate.
12 $150 $884
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.1% high complexity
84.8% medium
15.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$7,493
Total received (2018-2024)
Avg $1,070/year across 7 years
Top 18% in FL for optician
54
Companies
381
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,785 (90.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$708 (9.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$997
2023
$996
2022
$1,443
2021
$1,092
2020
$412
2019
$1,182
2018
$1,371

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$1,600
Coloplast Corp
$640
Janssen Biotech, Inc.
$573
ABBVIE INC.
$520
PFIZER INC.
$463
Sumitomo Pharma America, Inc.
$447
Myovant Sciences Inc.
$259
COLOPLAST CORP
$220
Allergan Inc.
$217
180 Medical, Inc.
$184
Allergan, Inc.
$177
UROVANT SCIENCES INC
$170
Endo Pharmaceuticals Inc.
$161
Medtronic USA, Inc.
$124
Janssen Scientific Affairs, LLC
$118
Medtronic, Inc.
$111
Blue Earth Diagnostics Limited
$97
Intuitive Surgical, Inc.
$91
Ferring Pharmaceuticals Inc.
$88
Rochester Medical Corporation
$81
UroGen Pharma, Inc.
$80
Dornier MedTech America, Inc
$74
AbbVie, Inc.
$68
PROCEPT BioRobotics Corporation
$67
Boston Scientific Corporation
$61
Bayer Healthcare Pharmaceuticals Inc.
$60
BLUEWIND MEDICAL
$60
Merck Sharp & Dohme LLC
$59
TOLMAR Pharmaceuticals, Inc.
$53
Verity Pharmaceuticals Inc.
$42
Endo USA, Inc.
$40
Amgen Inc.
$37
Edwards Lifesciences Corporation
$32
Myriad Genetic Laboratories, Inc.
$32
AstraZeneca Pharmaceuticals LP
$32
AbbVie Inc.
$29
Sun Pharmaceutical Industries Inc.
$27
Bayer HealthCare Pharmaceuticals Inc.
$27
UROGEN PHARMA, INC.
$25
Novartis Pharmaceuticals Corporation
$24
ROCHESTER MEDICAL CORPORATION
$23
PROGENICS PHARMACEUTICALS, INC.
$23
Tempus AI, Inc
$21
Progenics Pharmaceuticals, Inc.
$19
CIVCO Medical Instruments
$19
Clarus Therapeutics Inc.
$17
Tolmar, Inc.
$15
BOSTON SCIENTIFIC CORPORATION
$15
Mission Pharmacal Company
$14
BIOPROTECT MEDICAL, INC.
$13
Avadel Specialty Pharmaceuticals, LLC
$12
Teva Pharmaceuticals USA, Inc.
$12
Antares Pharma, Inc.
$12
Janssen Pharmaceuticals, Inc
$9
Top 3 companies account for 37.5% of total payments
Associated products mentioned in payments ›
ADVANTAGE FIT · AQUABEAM ROBOTIC SYSTEM · AVEED · Androgel · Axumin · BENDEKA · BIOPROTECT BALLOON IMPLANT SYSTEM · BOTOX · BOTOX - UROLOGY · BOTOX THERAPEUTIC · CURE TWIST · Consumables & Accessories · DARZALEX · Da Vinci Surgical System · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENTLECATH · IMBRUVICA · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · LYNPARZA · Lumenis Pulse 120H · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · PLUVICTO · PROLARIS · PYLARIFY · Prolaris · Prolia · PureWick Female External Catheter · REVI · REZUM · SPEEDICATH · SpeediCath · TITAN · TOVIAZ · Trelstar · Uribel · VESICARE · Veozah · XIAFLEX · XT CDX · XTANDI · XYOSTED · Xtandi · YONSA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (91%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $14 per 100 Medicare services performed
Looking for an optician specialist in Pensacola?
Compare opticians in the Pensacola area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
56
Per 100K population
17.3
County median income
$65,715
Nearest hospital
BAPTIST HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Greskovich is a mixed practice specialist, with above-average Medicare volume (top 2% in FL), with low-engagement industry engagement in the top 18% of FL peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Greskovich experienced with testosterone injection?
Based on Medicare claims data, Dr. Greskovich performed 32,610 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Greskovich receive payments from pharmaceutical companies?
Yes. Dr. Greskovich received a total of $7,493 from 54 companies across 381 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Greskovich's costs compare to other opticians in Pensacola?
Dr. Greskovich's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Greskovich) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →